Search for adam friedman - Practical Dermatology

January 21, 2020

FDA Follow-Up Study: Sunscreen Active Ingredients Are Absorbed by Bloodstream

Digital Supplement | December 2019 Supplement

Mechanism of Action Matters: A Review of New and Emerging Biologics

Joel L. Cohen, MD, FAAD; Adam Friedman, MD, FAAD; Alan Menter, MD, FAAD; and Joel M. Gelfand, MD, MSCE

Feature | December 2019

2019 In Review

A look back at approvals, data, and industry developments of the year.

Ask an Expert: How Do You Treat Hidradenitis Suppurativa? thumbnail

Video | November 26, 2019

Ask an Expert: How Do You Treat Hidradenitis Suppurativa?

Ask an Expert

In the second video in a series, Steven Cohen, MD talks about standard and new treatments for hidradenitis suppurativa. He talks to host Adam...

Steven Cohen, MD; and Adam Friedman, MD, FAAD

Digital Supplement | October 2019 Supplement

Emollient-Based Therapy for AD: A Potential Role for Rebalancing the Microbiome

Adam Friedman, MD, FAAD

Feature | October 2019

Currents: Does the Microbiome Matter?

Ask an Expert: What's the Role for Infliximab in HS? thumbnail

Video | September 27, 2019

Ask an Expert: What's the Role for Infliximab in HS?

Ask an Expert

Evidence shows that infliximab, with its weight-based dosing, can be effective for hidradenitis suppurative. Steven Cohen, MD discusses the data and...

Steven Cohen, MD; and Adam Friedman, MD, FAAD

Ask an Expert: What Do We Know about QoL in Hidradenitis Suppurativa thumbnail

Video | September 27, 2019

Ask an Expert: What Do We Know about QoL in Hidradenitis Suppurativa

Ask an Expert

With a surge in new research over the last decade, dermatologists are learning more about Hidradenitis Suppurativa, comorbidities, and quality...

Adam Friedman, MD, FAAD; and Steven Cohen, MD

Atopic Dermatitis: The Critical Need for Treatment thumbnail

Video | September 25, 2019

Atopic Dermatitis: The Critical Need for Treatment

Eczema Awareness 2019

The therapeutic landscape for atopic dermatitis is expanding, as is understanding of the disease and its impact. More than ever, patients need access...

Adam Friedman, MD, FAAD